药品安全从行政监管走向协同治理的路径审视——基于“山东疫苗事件”的考察

发布时间：2018-07-09 09:34

本文选题：药品安全 + 行政监管　；参考：《天津行政学院学报》2017年03期

【摘要】：公共健康领域安全风险的不确定性与复杂性亟待协同治理予以纾解。一桩山东疫苗的"旧案"诱致大规模行政问责与系列政策调整,促使药品安全监管逐向走向协同治理,但作为事务领域长期游离于治理之外。这主要囿于行政沟通的效能偏低、行业政策调适的协同性不高以及部分官员热衷于"共治"的"民主"解读。实践形成的"媒体驱动型"治理格局存在公器私用的空间,难以避免社会恐慌与信任滑坡的蔓延,且容易刺激行政问责的安抚性与慰藉式偏好。只有基于政府部门的有效合作、放松管制、培育领导力以及共享裁量权与共担责任,才能更好地构建"政府引导型"的协同治理以避免陷入回应性误区。
[Abstract]:The uncertainty and complexity of safety risk in public health field need to be alleviated urgently. An "old case" of Shandong vaccine induces large-scale administrative accountability and a series of policy adjustments, which urges drug safety supervision to be managed in a coordinated way, but as a field of affairs, it has been outside of governance for a long time. This is mainly due to the low efficiency of administrative communication, the low coordination of industrial policy adjustment and the democratic interpretation of "co-governance" by some officials. The "media driven" governance pattern formed by practice has room for public and private use, it is difficult to avoid the spread of social panic and trust slide, and it is easy to stimulate the appeasement and comfort preference of administrative accountability. Only based on the effective cooperation of government departments, deregulation, leadership, and sharing discretion and shared responsibility, can we better build a "government-led" collaborative governance to avoid falling into the fallacy of responsiveness.
【作者单位】：国际关系学院;
【基金】：国家社会科学基金项目“药品安全协同治理的运行机制与实践路径研究”(15CZZ017) 北京市社会科学基金一般项目“北京市食品药品安全协同治理的现代化路径研究”(16ZGB004)
【分类号】：D630

【相似文献】